Supplement With Calcium or Alendronate Suppresses Osteopenia Due to Long Term Rabeprazole Treatment in Female Mice: Influence on Bone TRAP and Osteopontin Levels

• 主要な著者: Aly A.M. Shaalan (著者), Mohamed El-Sherbiny (著者), Taghrid B. El-Abaseri (著者), Mohamed Z. Shoaeir (著者), Tarek M. Abdel-Aziz (著者), Magda I. Mohamed (著者), Sawsan A. Zaitone (著者), Hala M. F. Mohammad (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2020-05-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background and PurposeRabeprazole, a proton pump inhibitor (PPIs) is much endorsed to patients with increased gastric acidity. PPIs were accused to have osteoporotic effects on patients who chronically use them. The point of the current investigation was to decide the impact of rabeprazole on osteop...